|
Adeza Biomedical is dedicated to improving Women's Healthcare.
Adeza's tests assist healthcare professionals to understand
and manage the risks of preterm birth and unexplained infertility.
- FullTerm™, The Fetal
Fibronectin Test: a simple test
for fetal fibronectin, a unique protein, whose presence
between 22 to 35 weeks of gestation is the clinically
proven predictor of impending preterm birth.
- E-tegrity® Test: a
test to assess the feasibility of embryo implantation
by determining the presence of the Beta-3 integrin protein.
|
